While these studies referred to mostly extra-meningeal SFTs, a large study from 2013 on TERT promoter mutations in 1515 CNS tumors found TERT promoter mutations in 50% (8/16) of meningeal SFTs [41]. The gene discussed is TERT; the disease is central nervous system neoplasm.